| Literature DB >> 29975742 |
Misa Sumi1, Takashi Nakamura1.
Abstract
We evaluated apparent diffusion coefficient (ADC) histogram parameters for predicting the outcomes of patients with salivary gland carcinoma. Diffusion-weighted MR imaging was performed in 20 patients with salivary gland carcinoma, and ADCs were determined using b-values of 500 and 1000 s/mm2. ADC histogram parameters (mean, median, percentage tumor area with distinctive ADC values [pADC], skewness, and kurtosis) were analyzed. The patients were followed for 5-136 months after primary surgery. The ADC histogram parameters and T (pT), N(pN), and M categories of the primary tumors were assessed for the prognostic importance using Cox proportional hazards models, logistic regression analysis, and receiver operating characteristic (ROC) analysis. Cohen's d was determined for evaluating the importance of differences in the parameters between two patient groups with different outcomes. Six patients died of cancer (DOC) within 3 years after the primary surgery. Cox proportional hazards models indicated that ADC mean (95% CI = 0.494-0.977, p = 0.034), ADC median (95% CI = 0.511-0.997, p = 0.048), pADC with extremely low (<0.6 mm2/s) ADC (95% CI = 1.013-1.082, p = 0.007), kurtosis (95% CI = 1.166-7.420, p = 0.023), and pN classification (95% CI = 1.196-4.836, p = 0.012) were important factors of cancer death risk. ROC analyses indicated that the pADC <0.6 ×10(-3) mm2/s was the best prognostic predictor (p <0.001; AUC = 0.929) among the ADC and TNM classification parameters that were significant in a univariate logistic regression analysis. Cohen's d values between the DOC and survived patients for the ADC mean, ADC median, pADC with extremely low ADC, and kurtosis were 1.06, 1.04, 2.12, and 1.13, respectively. These results suggest that ADC histogram analysis may be helpful for predicting the outcomes of patients with salivary gland carcinoma.Entities:
Mesh:
Year: 2018 PMID: 29975742 PMCID: PMC6033457 DOI: 10.1371/journal.pone.0200291
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Histological subtypes and ADC parameters of 20 salivary gland carcinomas.
| subtype (n) | mean | median | skewness | kurtosis | pADC (percentage tumor area with) | DOC | |||
|---|---|---|---|---|---|---|---|---|---|
| x10-3mm2/s | x10-3mm2/s | <0.6 ADC | 0.6≤ADC<1.2 | 1.2≤ADC<1.8 | ≥1.8 ADC | ||||
| CxPA (4) | 1.23 ± 0.19 | 1.18 ± 0.20 | 0.22 ± 0.70 | 0.58 ± 0.46 | 4.9 ± 5.8 | 46.1 ± 24.0 | 39.4 ± 16.4 | 9.7 ± 8.7 | 0 |
| ACCa (4) | 1.03 ± 0.22 | 1.02 ± 0.22 | 0.06 ± 0.30 | 0.24 ± 0.63 | 6.8 ± 7.0 | 66.0 ± 29.5 | 23.9 ± 26.0 | 3.3 ± 4.7 | 1 |
| EMC (2) | 1.56 ± 0.13 | 1.40 ± 0.04 | 0.39 ± 0.05 | -0.69 ± 0.99 | 0.5 ± 0.4 | 29.5 ± 9.7 | 42.7 ± 25.8 | 27.3 ± 15.7 | 0 |
| SDC (2) | 0.78 ± 0.23 | 0.77 ± 0.27 | 0.44 ± 0.27 | 0.44 ± 0.24 | 30.5 ± 31.4 | 61.4 ± 25.3 | 8.1 ± 6.2 | 0 ± 0 | 2 |
| ANOS (3) | 0.90 ± 0.11 | 0.82 ± 0.04 | 0.82 ± 0.76 | 1.32 ± 1.66 | 14.5 ± 10.1 | 70.8 ± 20.7 | 9.5 ± 9.9 | 5.3 ± 6.8 | 1 |
| MEC (3) | 0.90 ± 0.12 | 0.88 ± 0.13 | 0.13 ± 0.64 | 0.88 ± 0.68 | 14.4 ± 18.8 | 76.5 ± 25.1 | 7.9 ± 5.0 | 1.2 ± 2.0 | 1 |
| LEC (1) | 0.77 | 0.74 | 0.49 | -0.59 | 10.4 | 89.6 | 0 | 0 | 0 |
| SCCa (1) | 0.44 | 0.38 | 0.83 | 0.81 | 72.3 | 25.5 | 2.2 | 0 | 1 |
CxPA, Carcinoma ex pleomorphic adenoma; ACCa, adenoid cystic carcinoma; EMC, epithelial-myoepithelial carcinoma; SDC, salivary duct carcinoma; ANOS, adenocarcinoma not otherwise specified, poorly differentiated; MEC, mucoepidermoid carcinoma; LEC, lymphoepithelial carcinoma; SCCa, small cell carcinoma. ADC histogram values are expressed as mean ± s.d. ADC values (mean, median, and pADC threshold values) are expressed in ×10-3mm2/s.
¶, DOC, died of cancer: ACCa, lung metastasis (n = 1); SDC, lung/bone/liver metastasis (n = 1), neck recurrence (n = 1); ANOS, lung metastasis (n = 1); MEC, lung metastasis/neck recurrence (n = 1); SCCa, liver metastasis/abdominal lymph node metastasis/neck recurrence (n = 1).
Status of surgical margins, additional treatment after the initial surgery, and prognosis of 20 patients with salivary gland carcinoma.
| surgical margin | n | additional treatments | n | prognosis | |
|---|---|---|---|---|---|
| survived | DOC | ||||
| negative | 14 | none | 12 | 9 | 3 |
| radiotherapy | 1 | 1 | 0 | ||
| chemotherapy | 1 | 0 | 1 | ||
| positive | 6 | none | 1 | 0 | 1 |
| radiotherapy | 1 | 1 | 0 | ||
| chemotherapy | 2 | 2 | 0 | ||
| chemoradiotherapy | 2 | 1 | 1 | ||
| total | 20 | 20 | 14 | 6 | |
¶, histological evidence for the presence (positive) or absence (negative) of invasive tumor at the margin of resection.
‡, The treatments included chemo- and/or radiotherapy that were performed after the initial surgery.
§, These patients did not receive any additional treatment before recurrence occurred. Patients with recurrence had been treated by combinations of radiotherapy and chemotherapy.
†, This patient did not receive chemoradiotherapy due to severely impaired respiratory function.
DOC, died of cancer
Comparison of ADC parameters between patients who died of cancer and those who were alive at the end of the follow-up periods.
| DOC | survived | p value | |
|---|---|---|---|
| ADC parameters | (mean ± s.d.) | (mean ± s.d.) | |
| mean (×10−3 mm2/s) | 0.81 ± 0.26 | 1.10 ± 0.28 | |
| median (×10−3 mm2/s) | 0.78 ± 0.28 | 1.05 ± 0.25 | 0.080 |
| percentage tumor area with | |||
| <0.6 ADC | 34.3 ± 24.8 | 5.1 ± 5.2 | |
| 0.6≤ADC<1.2 | 48.2 ± 17.7 | 64.1 ± 28.5 | 0.148 |
| 1.2≤ADC<1.8 | 14.8 ± 12.9 | 22.9 ± 23.3 | 0.335 |
| ≥1.8 ADC | 2.7 ± 3.9 | 7.8 ± 11.3 | 0.152 |
| skewness | 0.58 ± 0.29 | 0.25 ± 0.58 | 0.112 |
| kurtosis | 1.14 ± 0.95 | 0.20 ± 0.78 | 0.066 |
| UICC TNM classification | no. of patients | no. of patients | |
| T classificaton | 0.430 | ||
| Tis | 0 | 2 | |
| T2 | 0 | 4 | |
| T3 | 2 | 3 | |
| T4 | 4 | 5 | |
| N classification | |||
| N0 | 0 | 12 | |
| N1 | 1 | 0 | |
| N2b | 1 | 2 | |
| N3b | 3 | 1 | |
| M classification | 0.521 | ||
| M0 | 5 | 13 | |
| M1 | 1 | 1 | |
| age | (mean ± s.d.) | (mean ± s.d.) | |
| 62 ± 16 | 60 ± 12 | 0.773 | |
| status of surgical margins | no. of patients | no. of patients | 1.000 |
| negative | 4 | 10 | |
| positive | 2 | 4 | |
| additional treatments | no. of patients | no. of patients | 1.000 |
| none | 4 | 9 | |
| radio- and/or chemotherapy | 2 | 5 |
¶, DOC, patients who died of cancer (DOC) within the first 3 years after the primary surgery; survived, patients who survived beyond 3 years after the primary surgery.
§, Welch’s test for ADC histogram parameters and ages; or Fisher’s exact test for UICC TNM classification grades, status of surgical margins, and additional treatments.
‡, ADC thresholds are expressed in ×10−3 mm2/s.
Age variables did not meet the proportional hazard assumption and thus were excluded from the analysis. Bold p values indicate statistically significant differences.
Univariate Cox-proportional hazard regression models for the correlations between ADC parameters and the survival of patients with salivary gland carcinoma.
| unadjusted hazard ratio | p value | |||
|---|---|---|---|---|
| per | 95% CI | |||
| ADC parameters | ||||
| mean | 0.71 | 1 × 10−4 mm2/s | 0.494–0.977 | |
| median | 0.73 | 1 × 10−4 mm2/s | 0.511–0.997 | |
| percentage tumor area with | ||||
| <0.6 ADC | 1.05 | 1% | 1.013–1.082 | |
| 0.6≤ADC<1.2 | 0.98 | 1% | 0.949–1.013 | 0.262 |
| 1.2≤ADC<1.8 | 0.98 | 1% | 0.930–1.022 | 0.400 |
| ≥1.8 ADC | 0.93 | 1% | 0.749–1.032 | 0.216 |
| skewness | 2.40 | 1 | 0.572–8.869 | 0.221 |
| kurtosis | 2.88 | 1 | 1.166–7.420 | |
| UICC TNM classification | ||||
| T classification | 2.79 | 1 grade | 0.998–15.28 | 0.051 |
| N classification | 2.24 | 1 grade | 1.196–4.836 | |
| M classification | 2.19 | 1 grade | 0.114–13.822 | 0.513 |
| age | 1.29 | ≥60 vs <60 years | 0.239–6.998 | 0.754 |
| status of surgical margins | 1.38 | positive vs negative | 0.192–7.107 | 0.713 |
| additional treatments | 1.00 | none vs performed | 0.195–7.204 | 0.999 |
Hazard ratios are expressed per indicated units. 95% CI, 95% confidence interval.
‡, ADC thresholds are expressed in × 10−3 mm2/s.
†, n = 2, 4, 5, 9 for T1s, T2, T3, and T4
patients, respectively.
¶, n = 12, 1, 3, and 4 for N0, N1, N2b, and N3b patients, respectively.
§, n = 18 and 2 for M0 and M1 patients, respectively.
Age variables did not meet the proportional hazard assumption and thus were excluded from the analysis. Bold p values indicate statistically significant differences (p <0.05).
Univariate logistic regression and ROC analyses for the correlations between ADC parameters and cancer death in 20 patients with salivary gland carcinoma.
| univariate logistic regression analysis | ROC analysis | |||||
|---|---|---|---|---|---|---|
| unadjusted odds ratio | 95% CI | p value | cutoff threshold | AUC | ||
| per | ||||||
| ADC parameters | ||||||
| mean | 0.62 | 1 × 10−4 mm2/s | 0.357–1.058 | ≤9.44 × 10−4 mm2/s | 0.762 | |
| median | 0.64 | 1 × 10−4 mm2/s | 0.382–1.066 | ≤7.56 × 10−4 mm2/s | 0.738 | |
| percentage tumor area with | ||||||
| <0.6 ADC | 1.28 | 1% | 0.964–1.686 | ≥8.3% | 0.929 | |
| 0.6≤ADC<1.2 | 0.97 | 1% | 0.935–1.016 | 0.195 | ||
| 1.2≤ADC<1.8 | 0.98 | 1% | 0.926–1.033 | 0.395 | ||
| ≥1.8 ADC | 0.92 | 1% | 0.771–1.087 | 0.214 | ||
| skewness | 3.81 | 1 | 0.453–31.996 | 0.186 | ||
| kurtosis | 4.73 | 1 | 0.846–26.394 | ≥0.61 | 0.798 | |
| UICC TNM classification | ||||||
| T classification | 3.25 | 1 grade | 0.795–13.913 | 0.054 | ||
| N classification | 2.79 | 1 grade | 1.124–6.942 | ≥N1 | 0.821 | |
| M classification | 2.60 | 1 grade | 0.135–50.049 | 0.531 | ||
| age | 1.33 | ≥60 vs <60 years | 0.196–9.083 | 0.769 | ||
| status of surgical margins | 1.25 | positive vs negative | 0.160–9.765 | 0.832 | ||
| additional treatments | 1.11 | none vs performed | 0.148–8.367 | 0.919 | ||
§, Odds ratios are expressed as those per indicated units. 95% CI, 95% confidence interval.
†, These cutoff thresholds yielded 83% sensitivity, 64% specificity, 70% accuracy for ADC mean; 50% sensitivity, 93% specificity, and 80% accuracy for ADC median; 100% sensitivity, 71% specificity, and 80% accuracy for pADC <0.6 ×10−3 mm2/s; and 83% sensitivity, 71% specificity, and 75% accuracy for ADC kurtosis; 83% sensitivity, 79% specificity, 80% accuracy for N classification. AUC, area under curve
‡, ADC thresholds are expressed in ×10−3 mm2/s.
*, n = 2, 4, 5, 9 for T1s, T2, T3, and T4 patients, respectively.
**, n = 12, 1, 3, and 4 for N0, N1, N2b, and N3b patients, respectively.
***, n = 18 and 2 for M0 and M1patients, respectively. Age variables did not meet the proportional hazard assumption and thus were excluded from the analysis. Bold p values indicate statistically significant differences (p <0.05).